{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T16:41:51Z","timestamp":1768322511736,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,3,20]],"date-time":"2013-03-20T00:00:00Z","timestamp":1363737600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s10557-013-6453-1","type":"journal-article","created":{"date-parts":[[2013,3,19]],"date-time":"2013-03-19T05:10:14Z","timestamp":1363669814000},"page":"309-314","source":"Crossref","is-referenced-by-count":12,"title":["Ghrelin Could be a Candidate for the Prevention of In-Stent Restenosis"],"prefix":"10.1007","volume":"27","author":[{"given":"Z. W.","family":"Shu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X. J.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X. R.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,3,20]]},"reference":[{"key":"6453_CR1","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1755-5922.2010.00155.x","volume":"29","author":"MS Kim","year":"2011","unstructured":"Kim MS, Dean LS. In-stent restenosis. Cardiovasc Ther. 2011;29:190\u20138.","journal-title":"Cardiovasc Ther"},{"key":"6453_CR2","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","volume":"402","author":"M Kojima","year":"1999","unstructured":"Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656\u201360.","journal-title":"Nature"},{"key":"6453_CR3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.coph.2005.10.006","volume":"6","author":"EA Garcia","year":"2006","unstructured":"Garcia EA, Korbonits M. Ghrelin and cardiovascular health. Curr Opin Pharmacol. 2006;6:142\u20137.","journal-title":"Curr Opin Pharmacol"},{"key":"6453_CR4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1677\/JME-10-0019","volume":"45","author":"R Granata","year":"2010","unstructured":"Granata R, Baragli A, Settanni F, Scarlatti F, Ghigo E. Unraveling the role of the ghrelin gene peptides in the endocrine pancreas. J Mol Endocrinol. 2010;45:107\u201318.","journal-title":"J Mol Endocrinol"},{"key":"6453_CR5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2008.01.017","volume":"132","author":"J Yang","year":"2008","unstructured":"Yang J, Brown MS, Liang G, Grishin NV, Goldstein JL. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell. 2008;132:387\u201396.","journal-title":"Cell"},{"key":"6453_CR6","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1161\/01.CIR.0000149746.62908.BB","volume":"110","author":"N Nagaya","year":"2004","unstructured":"Nagaya N, Moriya J, Yasumura Y, Uematsu M, Ono F, Shimizu W, et al. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation. 2004;110:3674\u20139.","journal-title":"Circulation"},{"key":"6453_CR7","doi-asserted-by":"crossref","first-page":"H426","DOI":"10.1152\/ajpheart.00643.2007","volume":"294","author":"T Soeki","year":"2008","unstructured":"Soeki T, Kishimoto I, Schwenke DO, Tokudome T, Horio T, Yoshida M, et al. Ghrelin supresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction. Am J Physiol Heart Circ Physiol. 2008;294:H426\u201332.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"6453_CR8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00005344-200402000-00001","volume":"43","author":"L Chang","year":"2004","unstructured":"Chang L, Ren Y, Liu X, Li WG, Yang J, Geng B, et al. Protective effects of ghrelin on ischemia\/reperfusion injury in the isolated rat heart. J Cardiovasc Pharmacol. 2004;43:165\u201370.","journal-title":"J Cardiovasc Pharmacol"},{"key":"6453_CR9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11883-005-0074-5","volume":"7","author":"DE Drachman","year":"2005","unstructured":"Drachman DE, Simon DI. Inflammation as a mechanism and therapeutic target for in-stent restenosis. Curr Atheroscler Rep. 2005;7:44\u20139.","journal-title":"Curr Atheroscler Rep"},{"key":"6453_CR10","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.surg.2007.09.039","volume":"143","author":"T Waseem","year":"2008","unstructured":"Waseem T, Duxbury M, Ito H, Ashley SW, Robinson MK. Exogenous Ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways. Surgery. 2008;143:334\u201342.","journal-title":"Surgery"},{"key":"6453_CR11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2174\/1570161053586868","volume":"3","author":"V Sharma","year":"2005","unstructured":"Sharma V, McNeill JH. The emerging roles of leptin and Ghrelin in cardiovascular physiolosy and pathophysioloy. Curr Vasc Pharmacol. 2005;3:169\u201380.","journal-title":"Curr Vasc Pharmacol"},{"key":"6453_CR12","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1161\/01.CIR.0000127956.43874.F2","volume":"109","author":"WG Li","year":"2004","unstructured":"Li WG, Gavrila D, Liu X, Wang L, Gunnlaugsson S, Stoll LL, et al. Ghrelin inhibits pro-inflammatory responses and nuclear factor kappaB activation in human endothelial cells. Circulation. 2004;109:2221\u20136.","journal-title":"Circulation"},{"key":"6453_CR13","first-page":"487","volume":"18","author":"B Deng","year":"2010","unstructured":"Deng B, Xie XM, Chen XB. Relationship of ghrelin level to inflammatory factor and endothelial relaxation function in metabolic syndrome patients. Chin J Arterioscler. 2010;18:487\u201391.","journal-title":"Chin J Arterioscler"},{"key":"6453_CR14","doi-asserted-by":"crossref","first-page":"E486","DOI":"10.1152\/ajpendo.00196.2004","volume":"288","author":"M Granado","year":"2005","unstructured":"Granado M, Priego T, Martin AI, Villan\u00faa MA, L\u00f3pez-Calder\u00f3n A. Anti-inflammatory effect of the Ghrelin agonist growth hormone releasing peptide-2 (GHRP-2) in arthritic rats. Am J Physiol Endocrinol Metab. 2005;288:E486\u201392.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"6453_CR15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1172\/JCI200421134","volume":"114","author":"VD Dixit","year":"2004","unstructured":"Dixit VD, Schaffer EM, Pyle RS, Collins GD, Sakthivel SK, Palaniappan R, et al. Ghrelin inhibits leptin-and activation-induced pro-inflammatory cytokine expression by human monocytes and T cells. J Clin Investig. 2004;114:57\u201366.","journal-title":"J Clin Investig"},{"key":"6453_CR16","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/jcb.20744","volume":"97","author":"D Zhao","year":"2006","unstructured":"Zhao D, Zhan Y, Zeng H, Moyer MP, Mantzoros CS, Pothoulakis C. Ghrelin stimulates interleukin-8 gene expression through protein kinase C-mediated NF-\u03baB pathway in human colonic epitheial cells. J Cell Biochem. 2006;97:1317\u201327.","journal-title":"J Cell Biochem"},{"key":"6453_CR17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.regpep.2004.06.016","volume":"122","author":"Q Xia","year":"2004","unstructured":"Xia Q, Pang W, Pan H, Zheng Y, Kang JS, Zhu SG. Effects of Ghrelin on the proliferation and secretion of splenic T lymphocytes in mice. Regul Pept. 2004;122:173\u20138.","journal-title":"Regul Pept"},{"key":"6453_CR18","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s10753-009-9149-8","volume":"32","author":"KB Chow","year":"2009","unstructured":"Chow KB, Cheng CH, Wise H. Anti-inflammatory activity of ghrelin in human carotid artery cells. Inflammation. 2009;32:402\u20139.","journal-title":"Inflammation"},{"key":"6453_CR19","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1440-1681.2005.04274.x","volume":"32","author":"MR Skilton","year":"2005","unstructured":"Skilton MR, Nakhla S, Sieveking DP, Caterson ID, Celermajer DS. Pathophysiological levels of the obesity related peptides resistin and ghrelin increase adhesion molecule expression on human vascular endothelial cells. Clin Exp Pharmacol Physiol. 2005;32:839\u201344.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"6453_CR20","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1016\/j.peptides.2009.09.004","volume":"30","author":"CX Huang","year":"2009","unstructured":"Huang CX, Yuan MJ, Huang H, Wu G, Liu Y, Yu SB, et al. Ghrelin inhibits post-infarct myocardial remodeling and improves cardiac function through anti-inflammation effect. Peptides. 2009;30:2286\u201391.","journal-title":"Peptides"},{"key":"6453_CR21","doi-asserted-by":"crossref","first-page":"231S","DOI":"10.1016\/S0041-1345(03)00243-4","volume":"35","author":"AR Marks","year":"2003","unstructured":"Marks AR. Rapamycin: signaling in vscular smooth muscle. Transplant Proc. 2003;35:231S\u20133S.","journal-title":"Transplant Proc"},{"key":"6453_CR22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/153857440403800102","volume":"38","author":"AI Willis","year":"2004","unstructured":"Willis AI, Pierre-Paul D, Stunpio BE, Gahtan V. Vascular smooth muscle cell migration:current research and clinical implications. Vasc Endovasc Surg. 2004;38:11\u201323.","journal-title":"Vasc Endovasc Surg"},{"key":"6453_CR23","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.bbrc.2005.02.062","volume":"29","author":"J Chen","year":"2005","unstructured":"Chen J, Han Y, Lin C, Zhen Y, Song X, Teng S, et al. PDGF-D contributes to neointimal hyperplasia in rat model of vessel injury. Biochem Biophys Res Commun. 2005;29:976\u201383.","journal-title":"Biochem Biophys Res Commun"},{"key":"6453_CR24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1600-0463.2005.apm1130204.x","volume":"113","author":"AM Lavezzi","year":"2005","unstructured":"Lavezzi AM, Ottaviani G, Matturri L. Biology of the smooth muscle cells in human atherosclerosis. APMIS. 2005;113:112\u201321.","journal-title":"APMIS"},{"key":"6453_CR25","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/01.ATV.0000208185.16371.97","volume":"26","author":"DX Deng","year":"2006","unstructured":"Deng DX, Spin JM, Tsalenko A, Vailaya A, Ben-Dor A, Yakhini Z, et al. Molecular signatures determining coronary artery and saphenous vein smooth muscle cell phenotypes: distinct responses to stimuli. Arterioscler Thromb Vasc Biol. 2006;26:1058\u201365.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"6453_CR26","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1745-7270.2008.00457.x","volume":"40","author":"M Zhan","year":"2008","unstructured":"Zhan M, Yuan F, Liu H, Chen H, Qiu X, Fang W. Inhibition of proliferation and apoptosis of vascular smooth muscle cells by ghrelin. Acta Biochim Biophys Sin (Shanghai). 2008;40:769\u201376.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"6453_CR27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.atherosclerosis.2008.06.015","volume":"203","author":"F Rossi","year":"2009","unstructured":"Rossi F, Castelli A, Bianco MJ, Bertone C, Brama M, Santiemma V. Ghrelin inhibits contraction and proliferation of human aortic smooth muscle cells by cAMP\/PKA pathway activation. Atherosclerosis. 2009;203:97\u2013104.","journal-title":"Atherosclerosis"},{"key":"6453_CR28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.regpep.2005.02.015","volume":"129","author":"GZ Li","year":"2005","unstructured":"Li GZ, Jiang W, Zhao J, Pan CS, Cao J, Tang CS, et al. Ghrelin blunted vascular calcification in vivo and in vitro in rats. Regul Pept. 2005;129:167\u201376.","journal-title":"Regul Pept"},{"key":"6453_CR29","doi-asserted-by":"crossref","first-page":"e33126","DOI":"10.1371\/journal.pone.0033126","volume":"7","author":"QH Liang","year":"2012","unstructured":"Liang QH, Jiang Y, Zhu X, Cui RR, Liu GY, Liu Y, et al. Ghrelin attenuates the osteoblastic differentiation of vascular smooth muscle cells through the ERK pathway. PLoS One. 2012;7:e33126.","journal-title":"PLoS One"},{"key":"6453_CR30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/FJC.0b013e31819c74dc","volume":"53","author":"CZ Hu","year":"2009","unstructured":"Hu CZ, Cao YL, Huo HY, Zhao WH, Hu J. Inhibitory effect of ghrelin on nicotine-induced VCAM-1expression in human umbilical vein endothelial cells. J Cardiovasc Pharmacol. 2009;53:241\u20135.","journal-title":"J Cardiovasc Pharmacol"},{"key":"6453_CR31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1530\/JME-10-0143","volume":"47","author":"YP Xu","year":"2011","unstructured":"Xu YP, Zhu JJ, Cheng F, Jiang KW, Gu WZ, Shen Z, et al. Ghrelin ameliorates hypoxia-induced pulmonary hypertension via phospho-GSK3\u03b2\/\u03b2-catenin signaling in neonatal rats. J Mol Endocrinol. 2011;47:33\u201343.","journal-title":"J Mol Endocrinol"},{"key":"6453_CR32","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.bbrc.2003.09.085","volume":"310","author":"Y Shimizu","year":"2003","unstructured":"Shimizu Y, Nagaya N, Teranishi Y, Imazu M, Yamamoto H, Shokawa T, et al. Ghrelin improves endothelial dysfunction through growth hormone-independent mechanisms in rats. Biochem Biophys Res Commun. 2003;310:830\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"6453_CR33","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1161\/CIRCULATIONAHA.105.553883","volume":"112","author":"M Tesauro","year":"2005","unstructured":"Tesauro M, Schinzari F, Iantorno M, Rizza S, Melina D, Lauro D, et al. Ghrelin improves endothelial function in patients with metabolic syndrome. Circulation. 2005;112:2986\u201392.","journal-title":"Circulation"},{"key":"6453_CR34","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1083\/jcb.200207165","volume":"159","author":"G Baldanzi","year":"2002","unstructured":"Baldanzi G, Filigheddu N, Cutrupi S, Catapano F, Bonissoni S, Fubini A, et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1\/2 and PI3-kinase\/AKT. J Cell Biol. 2002;159:1029\u201337.","journal-title":"J Cell Biol"},{"key":"6453_CR35","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bbrc.2007.08.021","volume":"362","author":"H Zhan","year":"2007","unstructured":"Zhan H, Liu G, Wang Q, Ding L, Cai H, Jiang H, et al. Effect of Ghrelin on human endothelial cells apoptosis induced by high glucose. Biochem Biophys Res Commun. 2007;362:677\u201381.","journal-title":"Biochem Biophys Res Commun"},{"key":"6453_CR36","first-page":"1037","volume":"35","author":"B Deng","year":"2010","unstructured":"Deng B, Fang L, Chen X, Chen M, Xie X. Effect of ghrelin on angiotensin II induced human umbilicus vein endothelial cell oxidative stress and endothelial cell injury. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010;35:1037\u201347.","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"6453_CR37","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/cbf.1736","volume":"29","author":"Y Xiang","year":"2011","unstructured":"Xiang Y, Li Q, Li M, Wang W, Cui C, Zhang J. Ghrelin inhibits AGEs-induced apoptosis in human endothelial cells involving ERK1\/2 and PI3K\/Akt pathways. Cell Biochem Funct. 2011;29:149\u201355.","journal-title":"Cell Biochem Funct"},{"key":"6453_CR38","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.peptides.2008.07.002","volume":"29","author":"F Rossi","year":"2008","unstructured":"Rossi F, Castelli A, Bianco MJ, Bertone C, Brama M, Santiemma V. Ghrelin induces proliferation in human aortic endothelial cells via ERK1\/2 and PI3K\/Akt activation. Peptides. 2008;29:2046\u201351.","journal-title":"Peptides"},{"key":"6453_CR39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jvs.2008.08.065","volume":"49","author":"N Hedayati","year":"2009","unstructured":"Hedayati N, Annambhotla S, Jiang J, Wang X, Chai H, Lin PH, et al. Growth hormone-releasing peptite ghrelin inhibits homocysteine-induced endothelial dysfunction in porcine coronary arteries and human endothelial cells. J Vasc Surg. 2009;49:199\u2013207.","journal-title":"J Vasc Surg"},{"key":"6453_CR40","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.atherosclerosis.2006.07.021","volume":"192","author":"F Rossi","year":"2007","unstructured":"Rossi F, Bertone C, Petricca S, Santiemma V. Ghrelin inhibits angiotensin-II induced migration of human aortic endothelial cells. Atherosclerosis. 2007;192:291\u20137.","journal-title":"Atherosclerosis"},{"key":"6453_CR41","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.peptides.2004.08.011","volume":"25","author":"MT Conconi","year":"2004","unstructured":"Conconi MT, Nico B, Guidolin D, Baiguera S, Spinazzi R, Rebuffat P, et al. Ghrelin inhibits FGF-2-mediated angiogenesis in vitro and in vivo. Peptides. 2004;25:2179\u201385.","journal-title":"Peptides"},{"key":"6453_CR42","first-page":"29","volume":"60","author":"A Ahluwalia","year":"2009","unstructured":"Ahluwalia A, Li A, Cheng G, Deng X, Tarnawski AS. Reduced ghrelin in endothelial cells plays important mechanistic role in aging-related impairment of angiogenesis. J Physiol Pharmacol. 2009;60:29\u201334.","journal-title":"J Physiol Pharmacol"},{"key":"6453_CR43","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1365-2613.2000.00143.x","volume":"81","author":"GA Ferns","year":"2000","unstructured":"Ferns GA, Avades TY. The mechanisms of coronary restenosis:insight from experimental models. Int J Exp Pathol. 2000;81:63\u201388.","journal-title":"Int J Exp Pathol"},{"key":"6453_CR44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejphar.2006.11.052","volume":"558","author":"HS Elbatarny","year":"2007","unstructured":"Elbatarny HS, Netherton SJ, Ovens JD, Ferguson AV, Maurice DH. Adiponectin, ghrelin, and leptin differentially influence human platelet and human vascular endothelial cell functions: implication in obesity-associated cardiovascular diseases. Eur J Pharmacol. 2007;558:7\u201313.","journal-title":"Eur J Pharmacol"},{"key":"6453_CR45","first-page":"716","volume":"32","author":"E Kantorova","year":"2011","unstructured":"Kantorova E, Chomova M, Kurca E, Sivak S, Zelenak K, Ku\u010dera P, et al. Leptin, adiponectin and ghrelin, new potential mediators of ischemic stroke. Neuroendocrinol Lett. 2011;32:716\u201321.","journal-title":"Neuroendocrinol Lett"},{"key":"6453_CR46","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.regpep.2010.10.009","volume":"166","author":"OF Arici","year":"2011","unstructured":"Arici OF, Cetin N. Protective role of ghrelin against carbon tetrachloride (CCl4)-induced coagulation disturbances in rats. Regul Pept. 2011;166:139\u201342.","journal-title":"Regul Pept"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-013-6453-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10557-013-6453-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-013-6453-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T03:25:21Z","timestamp":1562815521000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10557-013-6453-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,20]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["6453"],"URL":"https:\/\/doi.org\/10.1007\/s10557-013-6453-1","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,20]]}}}